Renaissance Technologies's MEDP Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 493.6K shares of Medpace Holdings, Inc. (MEDP) worth $253.78 M, representing 0.34% of the portfolio. First purchased in 2017-Q3, this long-term strategic position has been held for 33 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in MEDP, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2018, adding 446.0K shares. Largest reduction occurred in Q4 2018, reducing 296.4K shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Medpace Holdings (MEDP) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medpace Holdings (MEDP) Trades by Renaissance Technologies
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2017 | +85,100 | New Buy | 85,100 | $31.90 |
| Q4 2017 | +98,400 | Add 115.63% | 183,500 | $36.26 |
| Q1 2018 | -73,800 | Reduce 40.22% | 109,700 | $34.91 |
| Q2 2018 | +229,200 | Add 208.93% | 338,900 | $43.00 |
| Q3 2018 | +446,000 | Add 131.60% | 784,900 | $59.91 |
| Q4 2018 | -296,400 | Reduce 37.76% | 488,500 | $52.93 |
| Q1 2019 | -246,400 | Reduce 50.44% | 242,100 | $58.97 |
| Q2 2019 | +101,000 | Add 41.72% | 343,100 | $65.42 |
| Q3 2019 | +130,888 | Add 38.15% | 473,988 | $84.04 |
| Q4 2019 | +112,100 | Add 23.65% | 586,088 | $84.06 |
| Q1 2020 | +233,600 | Add 39.86% | 819,688 | $73.38 |
| Q2 2020 | +53,732 | Add 6.56% | 873,420 | $93.02 |
| Q3 2020 | -35,332 | Reduce 4.05% | 838,088 | $111.75 |
| Q4 2020 | -234,300 | Reduce 27.96% | 603,788 | $139.20 |
| Q1 2021 | -139,400 | Reduce 23.09% | 464,388 | $164.05 |
| Q2 2021 | -42,100 | Reduce 9.07% | 422,288 | $176.63 |
| Q3 2021 | -8,400 | Reduce 1.99% | 413,888 | $189.28 |
| Q4 2021 | -19,000 | Reduce 4.59% | 394,888 | $217.64 |
| Q1 2022 | -14,800 | Reduce 3.75% | 380,088 | $163.59 |
| Q2 2022 | -25,200 | Reduce 6.63% | 354,888 | $149.67 |
| Q3 2022 | -88,700 | Reduce 24.99% | 266,188 | $157.17 |
| Q4 2022 | -62,200 | Reduce 23.37% | 203,988 | $0.21 |
| Q1 2023 | +93,500 | Add 45.84% | 297,488 | $0.19 |
| Q2 2023 | -86,600 | Reduce 29.11% | 210,888 | $0.24 |
| Q3 2023 | +48,300 | Add 22.90% | 259,188 | $242.13 |
| Q4 2023 | -7,800 | Reduce 3.01% | 251,388 | $306.53 |
| Q1 2024 | +69,400 | Add 27.61% | 320,788 | $404.15 |
| Q2 2024 | +122,800 | Add 38.28% | 443,588 | $411.85 |
| Q3 2024 | +48,900 | Add 11.02% | 492,488 | $333.80 |
| Q4 2024 | +61,100 | Add 12.41% | 553,588 | $332.23 |
| Q1 2025 | +24,100 | Add 4.35% | 577,688 | $304.69 |
| Q2 2025 | +100,400 | Add 17.38% | 678,088 | $313.86 |
| Q3 2025 | -184,500 | Reduce 27.21% | 493,588 | $514.16 |
Renaissance Technologies's Medpace Holdings Investment FAQs
Renaissance Technologies first purchased Medpace Holdings, Inc. (MEDP) in Q3 2017, acquiring 85,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Medpace Holdings, Inc. (MEDP) for 33 quarters since Q3 2017. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's largest addition to Medpace Holdings, Inc. (MEDP) was in Q3 2018, adding 784,900 shares worth $47.02 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 493,588 shares of Medpace Holdings, Inc. (MEDP), valued at approximately $253.78 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Medpace Holdings, Inc. (MEDP) represents approximately 0.34% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's peak holding in Medpace Holdings, Inc. (MEDP) was 873,420 shares, as reported at the end of Q2 2020. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.